Paul S Appelbaum Selected Research

Paul S Appelbaum Research Topics

Disease

10	Schizophrenia (Dementia Praecox) 01/2024 - 03/2004
5	Mental Disorders (Mental Disorder) 02/2024 - 01/2011
4	Alzheimer Disease (Alzheimer's Disease) 07/2014 - 07/2005
3	Psychotic Disorders (Schizoaffective Disorder) 05/2024 - 01/2019
3	Dementia (Dementias) 01/2013 - 09/2004
3	Treatment-Resistant Depressive Disorder 08/2012 - 01/2011
2	Substance-Related Disorders (Drug Abuse) 01/2018 - 12/2007
2	Antisocial Personality Disorder (Antisocial Personality) 01/2017 - 01/2015
2	Cystic Fibrosis (Mucoviscidosis) 07/2014 - 02/2013
1	Gender Dysphoria 01/2023
1	Prolonged Grief Disorder 01/2023
1	Treatment-Resistant Schizophrenia 01/2023
1	Hemorrhage 01/2023
1	Infections 01/2023
1	Parkinson Disease (Parkinson's Disease) 01/2023
1	Mood Disorders (Mood Disorder) 01/2023
1	Neurocognitive Disorders (Clerambault Syndrome) 01/2023
1	Delirium 01/2022
1	Alcoholism (Alcohol Abuse) 07/2021
1	Neurologic Manifestations (Neurological Manifestations) 02/2021
1	Hypertension (High Blood Pressure) 01/2021
1	COVID-19 01/2021
1	Low Vision (Subnormal Vision) 11/2019
1	Opioid-Related Disorders (Opiate Addiction) 01/2018
1	Personality Disorders (Personality Disorder) 04/2017
1	Huntington Disease (Huntington's Disease) 07/2014
1	Tay-Sachs Disease 07/2014
1	Autistic Disorder (Autism) 07/2014
1	Breast Neoplasms (Breast Cancer) 02/2013
1	Adenomatous Polyposis Coli (Familial Adenomatous Polyposis) 02/2013
1	Ovarian Neoplasms (Ovarian Cancer) 02/2013
1	Familial Hypertrophic Cardiomyopathy (Cardiomyopathy, Familial Hypertrophic) 02/2013
1	Inborn Genetic Diseases (Disease, Hereditary) 01/2008
1	Essential Hypertension 12/2007
1	Stroke (Strokes) 06/2007
1	Ischemic Stroke 06/2007
1	Type 2 Diabetes Mellitus (MODY) 07/2005
1	Cognitive Dysfunction 09/2004

Drug/Important Bio-Agent (IBA)

5	Antipsychotic Agents (Antipsychotics)IBA 01/2024 - 03/2004
3	antineoplaston A10 (A 10)IBA 06/2016 - 07/2009
3	Prostaglandins DIBA 07/2014 - 01/2008
2	Opioid Analgesics (Opioids)IBA 07/2021 - 01/2018
2	Monoamine Oxidase (MAO)IBA 01/2017 - 01/2015
1	Dopamine Receptors (Dopamine Receptor)IBA 01/2023
1	Ketamine FDA LinkGeneric 01/2022
1	Illicit Drugs (Recreational Drugs)IBA 02/2021
1	boldenone undecylenate (Equipoise)IBA 01/2021
1	Polytetrafluoroethylene (Teflon)FDA Link 01/2019
1	SolutionsIBA 01/2018
1	Naltrexone (ReVia)FDA LinkGeneric 01/2018
1	EnzymesIBA 01/2017
1	N-trifluoroacetyladriamycinol (AD 92)IBA 06/2013
1	Investigational DrugsIBA 04/2013
1	factor V LeidenIBA 02/2013
1	VaccinesIBA 01/2013
1	N 556IBA 01/2011
1	carboxyl radical (COO-)IBA 01/2011
1	Cocaine (Cocaine HCl)IBA 12/2007
1	Heroin (Diamorphine)IBA 12/2007
1	Tissue Plasminogen Activator (Alteplase)FDA Link 06/2007
1	N 30IBA 07/2005

Therapy/Procedure

4	Assisted Suicide (Physician Assisted Suicide) 02/2024 - 04/2016
4	Deep Brain Stimulation 01/2023 - 01/2011
3	Precision Medicine 01/2021 - 11/2019
2	Secondary Prevention 01/2021 - 01/2019
2	Long-Term Care 07/2006 - 09/2004
1	Therapeutics 05/2024
1	Operative Surgical Procedures 01/2023
1	Device Removal (Removal, Device) 01/2023
1	AT protocol 08/2011